320 likes | 339 Views
חידושים בטיפול קרינתי לשד: קרינה מקוצרת. דיאנה מצייבסקי , מחלקה אונקולוגית, מכון קרינה. 24.04.13. Whole Breast Radiotherapy (WBRT). External beam radiotherapy. Standard tangential field. Simulation. Radiotherapy For Breast Cancer Increases Heart Disease Risk.
E N D
חידושים בטיפול קרינתי לשד: קרינה מקוצרת דיאנה מצייבסקי, מחלקה אונקולוגית, מכון קרינה 24.04.13
Whole Breast Radiotherapy (WBRT) External beam radiotherapy
Radiotherapy For Breast Cancer Increases Heart Disease Risk N Engl J Med 2013; 368:1055-1056March 14, 2013
Conventional Whole breast Radiotherapy plan Boost 2Gy per fraction 25 fractions 8 fractions
The UK standardisation of Breast Radiotherapy (START)-Trial A and B of Radiotherapy hypofracyionation for treatment of early breast cancer: a randomized trial
Hypofractionation • «START» • 25 х 2 Gy = 15 х 2,67 Gy
START Randomization 50 Gy- in 25 fractions 40 Gy- in 15 fraction 1105 1110
HypofractionatedRadiation Therapy for Breast Cancer RANDOMIZATION 50 Gy in 25 fractions 42,5 Gy in 16 fractions 612 622
Shorter fractionation schedules: ■No difference in local recurrence ■No difference in overall survival ■A significant decrease in acute radiation toxicity ■No difference in late skin toxicity, ischemic heart disease, or rib fractures ■No difference in breast appearance
What still is questionable? The effect not clear in large breasts The safety of shorter course in combination with chemotherapy or monoclonal antibodies (Herceptin, Pertuzumab)? The “boost” issue What about treatment for regional lymph nodes ?
Reasonable approach (supported by ASTRO/ESTRO) Women >50y Tumor < 5 cm Node negative Without prior chemo? Boost?
~ 80% of local recurrences after conservative surgery + WBRT occur in tumor bed region “Elsewhere” recurrences in breast rare after CS +/- WBRT Rationale for Partial Breast Irradiation
Partial Breast Radiotherapy Mammosite Interstitial Breast Brachytherapy 5 days-2 daily fractions
PBI: Where are we? • While several preliminary studies have had excellent 5-yr results, they contain only small numbers of highly-selected pts • NSABP B-39/RTOG : 10 yrs for data to mature
Consensus Statements on PBI: American Society of Breast Surgeons and American Brachytherapy Society. PBI “off protocol” should be limited to pts: age > 50 IDC histology or DCIS Tumor < 2 cm (including DCIS) Margin > 2 mm Lymph node - negative